Fellay Lab – Human Genomics of Infection and Immunity
We use large-scale genomics and bioinformatics to explore the impact of genetic variation on immune parameters and host-pathogen interactions. Our ambition is to shed new light on basic biological mechanisms and to pave the way toward more personalized approaches to medicine. At the crossroad between basic science and the clinical world, we are committed to translational genomic research, aiming at identifying, validating, and bringing to clinical use genetic markers of susceptibility to infectious diseases.
Switzerland's lockdown has sharply reduced the cases of COVID-19
EPFL researchers have modeled the effects of measures taken in the country to slow the spread of coronavirus. According to their estimates, the contamination rate has fallen by between 53% and 92%, depending on the canton, and people’s movements have been reduced by 30% to 80%.
“The world now has no choice but to count on science.”
Jacques Fellay, a professor at EPFL’s School of Life Sciences, talks about mutations of the novel coronavirus, variants in the human genome, and how they might affect the current pandemic.